Vacuna contra el virus papiloma humano: lo que necesitamos saber
Parra, A; Sarkis, C; Epelbaum, C.
Med. infant
; 21(2): 154-162, Junio 2014. tab, ilus
Artigo em Espanhol | LILACS | ID: biblio-913409
Similares
Consumption of Health-Related Videos and Human Papillomavirus Awareness: Cross-Sectional Analyses of a US National Survey and YouTube From the Urban-Rural Context.
Ability of epidemiological studies to monitor HPV post-vaccination dynamics: a simulation study.
Evidence-Based Storytelling for a Strategic Roadmap to Promote Cancer Prevention via Adolescent HPV Vaccination in Northern New England.
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
A Nationwide Epidemiological Survey of Adolescent Patients With Diverse Symptoms Similar to Those Following Human Papillomavirus Vaccination: Background Prevalence and Incidence for Considering Vaccine Safety in Japan.
Raising the HPV Vaccination Rate in Rural Northern New England Using Local Opinion Leaders.
Self-reported HPV vaccination and vaccination record linkage in the Australian Oral Diversity Study.
Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis.
"A vaccine that nonetheless remains apart": Papillomavirus and vaccination in France
[Interest of a geostatistical approach to analyze the geographical disparities in human papillomavirus vaccine coverage in France].